Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
During the cell cycle, DNA suffers several lesions that need to be repaired prior to entry into mitosis to preserve genome integrity in daughter cells. Toward this aim, cells have developed complex enzymatic machinery, the so-called DNA damage response (DDR), which is able to repair DNA, temporarily...
Main Authors: | Francesca Esposito, Raffaella Giuffrida, Gabriele Raciti, Caterina Puglisi, Stefano Forte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/19/10689 |
Similar Items
-
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
by: Manuela Mancini, et al.
Published: (2022-08-01) -
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
by: Manuela Mancini, et al.
Published: (2022-01-01) -
Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells
by: Gro Elise Rødland, et al.
Published: (2021-07-01) -
Combined evaluation of both WEE1 and phosphorylated cyclin dependent kinase 1 expressions in oral squamous cell carcinomas predicts cancer recurrence and progression
by: Yu-Hsueh Wu, et al.
Published: (2022-10-01) -
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
by: Hayden L. Bell, et al.
Published: (2023-09-01)